prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Her2, page 1 / 2. copy No. Examination: Intraoperative examination. Cost of diagnostic procedure. Gender: F. Material: 1. Partial organ resection - Lesion in the right breast - outer upper quad. Expected time of examination: 20 minutes (from receipt of material). Clinical diagnosis: Suspected breast cancer (PCI - cellulae atypicae, MMR and clinically-ca). Please review the tumour and. margins. Result of intraoperative examination: Carcinoma invasivum. Macroscopic description: Fragment of the right breast sized 8 x 7 x 4 cm with a 5 x 2 cm skin flap, marked typically, no RTG. Tumour sized 2.5 x 1.5 x cm in the cross section. Margins: 0.8 cm to the base; 1.3 cm to the front surface; 2.5 cm to the sternum; 3 cm to the axilla; 4 cm to the shoulder; 1.3 cm. to the lower boundary. Preliminary result: Carcinoma ductale invasivum NHG2 (3 + 2 + 2/9 mitoses/10 HPF - visual area 0.55 mm). Carcinoma ductale in situ, solid type. with high nuclear atypia with comedo necrosis and calcifications. Final diagnosis after all material are analysed. Results of immunohistochemical examination: No estrogen receptors found in neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2 protein stained with HercepTest™ by DAKO. Score = 2+, FISH verification recommended. Examination: Histopathological examination page 2 / 2. Gender: F. Microscopic description. Carcinoma ductale invasivum NGH2 (3 + 2 + 2/9 mitoses/ 10 HPF/ visual area diameter 0.55 mm). Carcinoma ductale in situ, solid type with high nuclear atypia with comedo necrosis and calcifications. Margins of normal tissues as in the macroscopic description. Reactivo lymphocytaria peritumoralis. Additionally, mastopathia fibrosa et cystica. Histopathological diagnosis: Carcinoma ductale invasivum et in situ mammae dextrae G2, pT2. Invasive ductal carcinoma of the right. breast. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 gene AMPLIFICATION NOT FOUND. Anna Malicka. Supplementary test: Including the examination No. Carcinoma ductale invasivum et in situ mammae dextrae. (NHG2, pT2, pNo).

expanded version (tokens=1015) : 
 Based on the breast pathology report, the following information can be extracted:

1. Histological classification:
- Invasive ductal carcinoma
- Ductal carcinoma in situ, solid type with high nuclear atypia, comedo necrosis, and calcifications

2. Subtype: HER2 positive

3. Description of necrosis: Comedo necrosis present in the ductal carcinoma in situ

4. Tumor infiltrating lymphocytes: Reactive lymphocytaria peritumoralis noted

5. Histological grade: NHG2 (3+2+2)

6. Nuclear grade: Not specified for the invasive ductal carcinoma

7. Lymphovascular invasion: Not mentioned in the report

8. Calcification: Present in the ductal carcinoma in situ

9. Receptor status: 
- Negative for estrogen receptors
- Negative for progesterone receptors
- HER2 protein expression detected by immunohistochemistry (score = 2+)

10. IHC and ancillary testing results:
- FISH verification recommended for HER2/neu gene amplification as the score was 2+ on immunohistochemistry but not definitive
- HER-2 gene amplification not found on FISH testing

Overall diagnosis: Carcinoma ductale invasivum et in situ mammae dextrae G2, pT2. Invasive ductal carcinoma of the right breast, HER2 positive, negative for estrogen and progester

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1140) : 
 The patient has HER2 positive invasive ductal and ductal carcinoma in situ (NHG2) with comedo necrosis, calcifications, and reactive lymphocytaria peritumoralis. Immunohistochemical tests show negative estrogen and progesterone receptor status and HER2 protein expression. FISH testing is needed to verify the HER2/neu gene amplification.

